[Asia Economy Reporter Ji Yeon-jin] Hwanin Pharmaceutical announced on the 28th that its consolidated sales in the first quarter increased by 7.6% year-on-year to 45.224 billion KRW, and operating profit rose by 66.7% to 12.074 billion KRW.



During this period, net profit increased by 55.4% to 9.924 billion KRW.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing